Clinical trial of blood-brain barrier disruption by pulsed ultrasound
The blood-brain barrier (BBB) limits the delivery of systemically administered drugs to the brain. Methods to circumvent the BBB have been developed, but none are used in standard clinical practice. The lack of adoption of existing methods is due to procedural invasiveness, serious adverse effects,...
Saved in:
Published in | Science translational medicine Vol. 8; no. 343; p. 343re2 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.06.2016
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The blood-brain barrier (BBB) limits the delivery of systemically administered drugs to the brain. Methods to circumvent the BBB have been developed, but none are used in standard clinical practice. The lack of adoption of existing methods is due to procedural invasiveness, serious adverse effects, and the complications associated with performing such techniques coincident with repeated drug administration, which is customary in chemotherapeutic protocols. Pulsed ultrasound, a method for disrupting the BBB, was shown to effectively increase drug concentrations and to slow tumor growth in preclinical studies. We now report the interim results of an ultrasound dose-escalating phase 1/2a clinical trial using an implantable ultrasound device system, SonoCloud, before treatment with carboplatin in patients with recurrent glioblastoma (GBM). The BBB of each patient was disrupted monthly using pulsed ultrasound in combination with systemically injected microbubbles. Contrast-enhanced magnetic resonance imaging (MRI) indicated that the BBB was disrupted at acoustic pressure levels up to 1.1 megapascals without detectable adverse effects on radiologic (MRI) or clinical examination. Our preliminary findings indicate that repeated opening of the BBB using our pulsed ultrasound system, in combination with systemic microbubble injection, is safe and well tolerated in patients with recurrent GBM and has the potential to optimize chemotherapy delivery in the brain. |
---|---|
AbstractList | The blood-brain barrier (BBB) limits the delivery of systemically administered drugs to the brain. Methods to circumvent the BBB have been developed, but none are used in standard clinical practice. The lack of adoption of existing methods is due to procedural invasiveness, serious adverse effects, and the complications associated with performing such techniques coincident with repeated drug administration, which is customary in chemotherapeutic protocols. Pulsed ultrasound, a method for disrupting the BBB, was shown to effectively increase drug concentrations and to slow tumor growth in preclinical studies. We now report the interim results of an ultrasound dose-escalating phase 1/2a clinical trial using an implantable ultrasound device system, SonoCloud, before treatment with carboplatin in patients with recurrent glioblastoma (GBM). The BBB of each patient was disrupted monthly using pulsed ultrasound in combination with systemically injected microbubbles. Contrast-enhanced magnetic resonance imaging (MRI) indicated that the BBB was disrupted at acoustic pressure levels up to 1.1 megapascals without detectable adverse effects on radiologic (MRI) or clinical examination. Our preliminary findings indicate that repeated opening of the BBB using our pulsed ultrasound system, in combination with systemic microbubble injection, is safe and well tolerated in patients with recurrent GBM and has the potential to optimize chemotherapy delivery in the brain. |
Author | Carpentier, Alexandre Chapelon, Jean-Yves Canney, Michael Horodyckid, Catherine Idbaih, Ahmed Leclercq, Delphine Beccaria, Kevin Capelle, Laurent Vignot, Alexandre Lafon, Cyril Karachi, Carine Hoang-Xuan, Khê Sanson, Marc Cornu, Philippe Delattre, Jean-Yves Reina, Vincent |
Author_xml | – sequence: 1 givenname: Alexandre surname: Carpentier fullname: Carpentier, Alexandre email: alexandre.carpentier@aphp.fr organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France. alexandre.carpentier@aphp.fr – sequence: 2 givenname: Michael surname: Canney fullname: Canney, Michael organization: CarThera, Institut du Cerveau et de la Moelle épinière (ICM), Paris F-75013, France – sequence: 3 givenname: Alexandre surname: Vignot fullname: Vignot, Alexandre organization: CarThera, Institut du Cerveau et de la Moelle épinière (ICM), Paris F-75013, France – sequence: 4 givenname: Vincent surname: Reina fullname: Reina, Vincent organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France – sequence: 5 givenname: Kevin surname: Beccaria fullname: Beccaria, Kevin organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France – sequence: 6 givenname: Catherine surname: Horodyckid fullname: Horodyckid, Catherine organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France – sequence: 7 givenname: Carine surname: Karachi fullname: Karachi, Carine organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France – sequence: 8 givenname: Delphine surname: Leclercq fullname: Leclercq, Delphine organization: AP-HP, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Service de Neuroradiologie, F-75013 Paris, France – sequence: 9 givenname: Cyril surname: Lafon fullname: Lafon, Cyril organization: INSERM, U1032, LabTau, Lyon F-69003, France – sequence: 10 givenname: Jean-Yves surname: Chapelon fullname: Chapelon, Jean-Yves organization: INSERM, U1032, LabTau, Lyon F-69003, France – sequence: 11 givenname: Laurent surname: Capelle fullname: Capelle, Laurent organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France – sequence: 12 givenname: Philippe surname: Cornu fullname: Cornu, Philippe organization: Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Service de Neurochirurgie, F-75013 Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France – sequence: 13 givenname: Marc surname: Sanson fullname: Sanson, Marc organization: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France. INSERM, U 1127, F-75013 Paris, France. CNRS, UMR 7225, F-75013, Paris, France. ICM, F-75013 Paris, France. AP-HP, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, F-75013 Paris, France – sequence: 14 givenname: Khê surname: Hoang-Xuan fullname: Hoang-Xuan, Khê organization: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France. INSERM, U 1127, F-75013 Paris, France. CNRS, UMR 7225, F-75013, Paris, France. ICM, F-75013 Paris, France. AP-HP, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, F-75013 Paris, France – sequence: 15 givenname: Jean-Yves surname: Delattre fullname: Delattre, Jean-Yves organization: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France. INSERM, U 1127, F-75013 Paris, France. CNRS, UMR 7225, F-75013, Paris, France. ICM, F-75013 Paris, France. AP-HP, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, F-75013 Paris, France – sequence: 16 givenname: Ahmed surname: Idbaih fullname: Idbaih, Ahmed organization: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013 Paris, France. INSERM, U 1127, F-75013 Paris, France. CNRS, UMR 7225, F-75013, Paris, France. ICM, F-75013 Paris, France. AP-HP, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, F-75013 Paris, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27306666$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8lqwzAYhEVpaZb2DUrRCziVZPuXfCwmXSCQS3oOWkFFkYxkH_L2FbSdwwx8hxlmg25jihahJ0p2lDJ4KdrPWcYSLtbspHRABNygNR06aIB1bIU2pXwTAqLt4R6tGG8JVK3Rfgw-ei0DnrOvnhxWISXTqCx9xErm7G3Gxpe8TLNPFV3xtIRiDV5CHS1pieYB3TlZ2eNfbtHX2_40fjSH4_vn-HpodEdgbhwntOcGrB5AKmG4A9631DIJYjCMd6bl0ilKlGaCOeVAtZ2hDqwVWgvHtuj5t3daVL16nrK_yHw9__9hPz1wUeA |
CitedBy_id | crossref_primary_10_1080_10717544_2023_2194579 crossref_primary_10_1073_pnas_1807105115 crossref_primary_10_1038_s41467_017_00845_5 crossref_primary_10_1088_1361_6560_acf2e3 crossref_primary_10_1177_1758835918780312 crossref_primary_10_3389_fnins_2020_00675 crossref_primary_10_3390_brainsci12020216 crossref_primary_10_1016_j_jconrel_2020_04_023 crossref_primary_10_1248_cpb_c20_00041 crossref_primary_10_1016_j_jconrel_2016_10_007 crossref_primary_10_1016_j_cej_2025_161514 crossref_primary_10_3390_life14111456 crossref_primary_10_1038_s41571_019_0177_5 crossref_primary_10_1039_D3NA01125A crossref_primary_10_1007_s11060_021_03929_x crossref_primary_10_1126_scitranslmed_abj4011 crossref_primary_10_1227_ons_0000000000001175 crossref_primary_10_1016_j_ultrasmedbio_2019_11_013 crossref_primary_10_1038_s41598_018_25904_9 crossref_primary_10_1007_s10311_021_01218_7 crossref_primary_10_2745_dds_34_116 crossref_primary_10_1016_j_ultrasmedbio_2018_09_020 crossref_primary_10_1016_j_dmpk_2022_100445 crossref_primary_10_1016_j_neurol_2023_03_013 crossref_primary_10_1186_s43046_024_00240_4 crossref_primary_10_1016_j_jconrel_2023_10_015 crossref_primary_10_1038_s41598_025_88379_5 crossref_primary_10_1016_j_addr_2021_01_012 crossref_primary_10_1016_j_addr_2020_06_010 crossref_primary_10_1016_j_addr_2017_06_011 crossref_primary_10_3389_fphar_2019_01562 crossref_primary_10_1007_s11060_024_04795_z crossref_primary_10_1007_s11060_021_03861_0 crossref_primary_10_2745_dds_34_385 crossref_primary_10_3390_ijms21010022 crossref_primary_10_1097_WNP_0000000000000488 crossref_primary_10_1016_j_ultras_2018_05_014 crossref_primary_10_1007_s13346_021_00963_0 crossref_primary_10_1140_epjp_s13360_021_01593_8 crossref_primary_10_1109_TUFFC_2023_3256268 crossref_primary_10_1177_0271678X211046129 crossref_primary_10_3390_diseases7030047 crossref_primary_10_1002_advs_202002026 crossref_primary_10_1016_j_trecan_2017_12_008 crossref_primary_10_1063_1_5124437 crossref_primary_10_1016_j_jddst_2023_105226 crossref_primary_10_1186_s40644_020_00312_3 crossref_primary_10_3390_pharmaceutics13091446 crossref_primary_10_1007_s10439_018_02141_9 crossref_primary_10_3390_cancers14153705 crossref_primary_10_1007_s00018_021_03904_9 crossref_primary_10_1021_acs_accounts_9b00277 crossref_primary_10_1016_j_jconrel_2023_02_009 crossref_primary_10_1038_s41598_022_06791_7 crossref_primary_10_1109_TBME_2022_3150781 crossref_primary_10_1038_s41565_019_0567_y crossref_primary_10_1016_j_jconrel_2019_10_044 crossref_primary_10_3390_pharmaceutics12100964 crossref_primary_10_1093_annonc_mdx106 crossref_primary_10_3340_jkns_2018_0180 crossref_primary_10_1109_TUFFC_2018_2866171 crossref_primary_10_1021_acsami_1c22803 crossref_primary_10_1159_000512111 crossref_primary_10_1007_s40263_020_00766_w crossref_primary_10_1109_TUFFC_2024_3420242 crossref_primary_10_3390_pharmaceutics16111383 crossref_primary_10_1007_s11060_023_04292_9 crossref_primary_10_1002_cjoc_202300642 crossref_primary_10_3390_pharmaceutics13122167 crossref_primary_10_2745_dds_33_115 crossref_primary_10_1021_acsanm_0c02297 crossref_primary_10_1109_TBME_2023_3322302 crossref_primary_10_2217_nnm_2018_0084 crossref_primary_10_1016_j_jconrel_2016_09_026 crossref_primary_10_1016_j_jconrel_2020_05_020 crossref_primary_10_3390_cimb45090485 crossref_primary_10_1371_journal_pone_0209094 crossref_primary_10_1002_cpim_83 crossref_primary_10_1016_j_jconrel_2021_06_009 crossref_primary_10_1080_10717544_2018_1461280 crossref_primary_10_1038_s41567_025_02785_0 crossref_primary_10_1002_adhm_202001343 crossref_primary_10_1021_acsbiomaterials_0c00014 crossref_primary_10_1126_sciadv_adg6075 crossref_primary_10_1016_j_ultrasmedbio_2021_02_016 crossref_primary_10_3390_pharmaceutics14010098 crossref_primary_10_1016_j_ebiom_2024_105235 crossref_primary_10_1021_acsbiomaterials_9b01979 crossref_primary_10_1109_TUFFC_2020_2964786 crossref_primary_10_1021_acsbiomaterials_4c00777 crossref_primary_10_1038_s41598_019_50147_7 crossref_primary_10_1080_02656736_2020_1783461 crossref_primary_10_1073_pnas_1716187114 crossref_primary_10_3390_cells10082032 crossref_primary_10_1016_j_mattod_2022_12_004 crossref_primary_10_1038_s41598_018_22571_8 crossref_primary_10_1039_D2CS01020H crossref_primary_10_1002_advs_202103148 crossref_primary_10_1016_j_neurom_2024_04_001 crossref_primary_10_1016_j_jconrel_2017_05_009 crossref_primary_10_1016_j_mayocpiqo_2020_04_006 crossref_primary_10_1016_j_device_2023_100068 crossref_primary_10_1177_0271678X17753514 crossref_primary_10_3390_brainsci12020289 crossref_primary_10_1016_j_neuint_2020_104952 crossref_primary_10_1038_s41573_021_00139_y crossref_primary_10_3389_fbioe_2021_803055 crossref_primary_10_3390_ijms232213954 crossref_primary_10_1111_cns_13788 crossref_primary_10_1038_s41598_019_49933_0 crossref_primary_10_1002_adma_202303180 crossref_primary_10_1002_biot_202400561 crossref_primary_10_1002_adma_202307664 crossref_primary_10_1016_j_xcrm_2024_101626 crossref_primary_10_1186_s40164_024_00512_8 crossref_primary_10_1158_1078_0432_CCR_19_0932 crossref_primary_10_1016_j_ultrasmedbio_2019_03_016 crossref_primary_10_3390_ijms241512411 crossref_primary_10_1021_acschemneuro_7b00188 crossref_primary_10_1016_j_jconrel_2024_03_020 crossref_primary_10_1126_sciadv_abf7390 crossref_primary_10_3390_pharmaceutics13111752 crossref_primary_10_1016_j_isci_2024_108852 crossref_primary_10_1016_j_wneu_2023_07_030 crossref_primary_10_1088_1361_6560_aafaa5 crossref_primary_10_1016_j_addr_2023_114820 crossref_primary_10_3390_cancers14153698 crossref_primary_10_1016_j_ultsonch_2017_02_020 crossref_primary_10_3390_cancers13225614 crossref_primary_10_1109_TUFFC_2024_3436918 crossref_primary_10_1016_j_addr_2024_115199 crossref_primary_10_3389_fphar_2020_00075 crossref_primary_10_1016_j_jconrel_2023_01_061 crossref_primary_10_1016_j_bbamem_2020_183298 crossref_primary_10_1080_17425247_2018_1547279 crossref_primary_10_1038_s41598_018_36340_0 crossref_primary_10_1038_s41467_019_12426_9 crossref_primary_10_1364_BOE_10_003139 crossref_primary_10_3390_pharmaceutics13071084 crossref_primary_10_1016_j_addr_2022_114539 crossref_primary_10_3390_brainsci11111429 crossref_primary_10_1016_j_ultrasmedbio_2020_08_012 crossref_primary_10_1016_j_brs_2020_02_024 crossref_primary_10_1073_pnas_2103280118 crossref_primary_10_37549_ARO1329 crossref_primary_10_1016_j_tins_2022_03_003 crossref_primary_10_1021_acs_nanolett_7b00616 crossref_primary_10_37549_ARO1325 crossref_primary_10_1038_s41598_021_91252_w crossref_primary_10_1093_noajnl_vdaa030 crossref_primary_10_1115_1_4051184 crossref_primary_10_1016_j_ultrasmedbio_2019_05_022 crossref_primary_10_1016_j_ultrasmedbio_2019_05_023 crossref_primary_10_1093_neuros_nyy115 crossref_primary_10_3390_pharmaceutics12121205 crossref_primary_10_1038_s42003_024_06404_1 crossref_primary_10_1007_s00018_017_2483_3 crossref_primary_10_1007_s10856_018_6032_x crossref_primary_10_1016_j_jcmg_2019_08_010 crossref_primary_10_1016_j_jocn_2024_110786 crossref_primary_10_1021_acsabm_3c00842 crossref_primary_10_1016_j_addr_2021_114043 crossref_primary_10_1016_j_jtcms_2021_07_003 crossref_primary_10_3389_fimmu_2021_721830 crossref_primary_10_1016_j_jconrel_2019_03_030 crossref_primary_10_1021_acsnano_9b04954 crossref_primary_10_1016_j_jddst_2024_106322 crossref_primary_10_3390_pharmaceutics13111980 crossref_primary_10_1080_10717544_2020_1833381 crossref_primary_10_1016_j_addr_2022_114517 crossref_primary_10_1039_D3SM00871A crossref_primary_10_1038_s41551_017_0029 crossref_primary_10_3390_jcm10122698 crossref_primary_10_1242_dmm_049531 crossref_primary_10_3389_fonc_2025_1507940 crossref_primary_10_3390_curroncol29110696 crossref_primary_10_1172_jci_insight_187328 crossref_primary_10_3171_2019_10_FOCUS19726 crossref_primary_10_1016_j_biomaterials_2021_120907 crossref_primary_10_1016_j_ultrasmedbio_2020_12_026 crossref_primary_10_3390_biomimetics3010004 crossref_primary_10_1038_s41598_021_94188_3 crossref_primary_10_1016_j_ijpharm_2025_125521 crossref_primary_10_1186_s12987_022_00402_3 crossref_primary_10_1038_s41551_018_0258_2 crossref_primary_10_3390_molecules28237733 crossref_primary_10_1080_14712598_2020_1713085 crossref_primary_10_1016_j_addr_2022_114583 crossref_primary_10_1007_s11095_022_03185_2 crossref_primary_10_1016_j_apacoust_2018_05_002 crossref_primary_10_3390_pharmaceutics13071053 crossref_primary_10_1016_j_ultrasmedbio_2020_07_004 crossref_primary_10_1038_s42003_022_03881_0 crossref_primary_10_1155_2019_2345203 crossref_primary_10_1016_j_ebiom_2024_105066 crossref_primary_10_2176_nmc_ra_2020_0175 crossref_primary_10_1016_j_neuron_2023_02_018 crossref_primary_10_1073_pnas_2306973121 crossref_primary_10_15212_bioi_2020_0028 crossref_primary_10_1093_ons_opz374 crossref_primary_10_1146_annurev_bioeng_062117_121238 crossref_primary_10_1158_1078_0432_CCR_23_2367 crossref_primary_10_2174_1389450119666180731095441 crossref_primary_10_1021_acsbiomaterials_2c00069 crossref_primary_10_1073_pnas_2309331120 crossref_primary_10_1002_smll_202200924 crossref_primary_10_3390_cells13040349 crossref_primary_10_1155_2019_9342796 crossref_primary_10_1016_j_ultrasmedbio_2020_06_021 crossref_primary_10_3390_brainsci11010084 crossref_primary_10_1016_j_addr_2017_07_007 crossref_primary_10_1016_j_ultrasmedbio_2023_02_017 crossref_primary_10_1038_srep45657 crossref_primary_10_1016_j_neo_2021_04_005 crossref_primary_10_1002_adfm_202414994 crossref_primary_10_1007_s11427_021_1971_x crossref_primary_10_1016_j_bioactmat_2021_05_038 crossref_primary_10_1039_C8RA10184A crossref_primary_10_1016_j_ymeth_2017_05_018 crossref_primary_10_1016_j_expneurol_2017_09_006 crossref_primary_10_3762_bjnano_12_64 crossref_primary_10_1158_1078_0432_CCR_20_3760 crossref_primary_10_1016_j_ultsonch_2024_106798 crossref_primary_10_18632_oncotarget_28018 crossref_primary_10_1038_s41598_021_85180_y crossref_primary_10_1080_14737140_2022_2110072 crossref_primary_10_1186_s40349_017_0105_z crossref_primary_10_1016_j_ultrasmedbio_2023_02_002 crossref_primary_10_1038_s41467_018_04529_6 crossref_primary_10_1016_j_pharmthera_2023_108518 crossref_primary_10_3390_molecules27082428 crossref_primary_10_1186_s12951_022_01464_z crossref_primary_10_3389_fphar_2019_01651 crossref_primary_10_1038_s42254_019_0074_y crossref_primary_10_1016_j_canlet_2020_02_013 crossref_primary_10_1016_j_pharmthera_2021_108022 crossref_primary_10_1016_j_ultrasmedbio_2020_06_007 crossref_primary_10_3389_fnana_2024_1469250 crossref_primary_10_3390_cancers14071627 crossref_primary_10_1016_j_nano_2018_01_021 crossref_primary_10_1038_s41467_024_48326_w crossref_primary_10_3390_pharmaceutics11050245 crossref_primary_10_53975_ykha_lrmn crossref_primary_10_2174_0109298673300897240602130258 crossref_primary_10_1016_j_neuroimage_2016_12_011 crossref_primary_10_3390_pharmaceutics14071498 crossref_primary_10_1038_s41568_019_0205_x crossref_primary_10_1088_1361_6560_aacf75 crossref_primary_10_1016_j_jconrel_2017_07_004 crossref_primary_10_1038_s43246_024_00721_y crossref_primary_10_1038_s41467_018_06808_8 crossref_primary_10_1016_j_neuroimage_2022_119402 crossref_primary_10_1002_mp_15500 crossref_primary_10_1002_adhm_202301062 crossref_primary_10_1016_j_clinre_2019_02_015 crossref_primary_10_1097_SCS_0000000000005454 crossref_primary_10_1016_j_pharma_2023_10_004 crossref_primary_10_1016_j_jneumeth_2022_109729 crossref_primary_10_1002_adhm_201700214 crossref_primary_10_1016_j_jconrel_2023_05_002 crossref_primary_10_1016_j_jconrel_2020_08_053 crossref_primary_10_1038_s41598_020_78657_9 crossref_primary_10_1002_jum_16245 crossref_primary_10_1038_s41598_019_51785_7 crossref_primary_10_1093_noajnl_vdz006 crossref_primary_10_3389_fphy_2020_547674 crossref_primary_10_1177_10738584221112861 crossref_primary_10_1021_acsbiomaterials_1c00276 crossref_primary_10_1002_adma_201905914 crossref_primary_10_3390_ijms20123081 crossref_primary_10_3390_pharmaceutics13071002 crossref_primary_10_3389_fphy_2022_791145 crossref_primary_10_1021_acsami_1c04990 crossref_primary_10_1093_brain_awab012 crossref_primary_10_3390_s24175635 crossref_primary_10_1007_s11064_019_02908_z crossref_primary_10_1016_j_ultsonch_2023_106319 crossref_primary_10_1088_1361_6560_ace23d crossref_primary_10_1121_10_0005066 crossref_primary_10_1016_j_ultrasmedbio_2021_04_005 crossref_primary_10_1038_s41582_020_00418_z crossref_primary_10_1016_j_biopha_2023_115450 crossref_primary_10_1007_s13311_018_00683_3 crossref_primary_10_1016_j_neo_2024_100990 crossref_primary_10_1146_annurev_chembioeng_092220_030853 crossref_primary_10_3390_pharmaceutics12111125 crossref_primary_10_1016_j_ultras_2021_106591 crossref_primary_10_1016_S1470_2045_23_00149_3 crossref_primary_10_3892_ol_2024_14573 crossref_primary_10_1088_1361_6560_ad8fed crossref_primary_10_1016_j_canlet_2022_216033 crossref_primary_10_1093_neuonc_noae135 crossref_primary_10_1259_bjr_20180601 crossref_primary_10_3390_pharmaceutics13081270 crossref_primary_10_1038_s41578_021_00394_w crossref_primary_10_1158_1078_0432_CCR_18_3643 crossref_primary_10_1016_j_ultrasmedbio_2023_01_007 crossref_primary_10_1016_j_jconrel_2018_10_034 crossref_primary_10_1080_21678707_2019_1560262 crossref_primary_10_1016_j_ultrasmedbio_2023_08_019 crossref_primary_10_1016_j_biomaterials_2022_121640 crossref_primary_10_1016_j_actbio_2018_04_029 crossref_primary_10_1016_j_addr_2024_115363 crossref_primary_10_1016_j_ultrasmedbio_2020_03_013 crossref_primary_10_1038_natrevmats_2017_24 crossref_primary_10_1080_17425247_2024_2438188 crossref_primary_10_3389_fimmu_2023_1259797 crossref_primary_10_3390_biomedicines12010008 crossref_primary_10_3233_HAB_160306 crossref_primary_10_1016_j_ncl_2020_09_009 crossref_primary_10_3233_JAD_179907 crossref_primary_10_1002_mds_27308 crossref_primary_10_1002_advs_202001675 crossref_primary_10_3389_fphar_2024_1418142 crossref_primary_10_1016_j_addr_2024_115274 crossref_primary_10_1016_j_addr_2024_115275 crossref_primary_10_1016_j_jconrel_2022_11_016 crossref_primary_10_1021_acs_langmuir_8b03779 crossref_primary_10_1021_acs_langmuir_8b03538 crossref_primary_10_2147_IJN_S231479 crossref_primary_10_1186_s13046_022_02349_7 crossref_primary_10_1080_17425247_2025_2462767 crossref_primary_10_1016_j_ccr_2018_03_010 crossref_primary_10_1016_j_neuron_2020_09_003 crossref_primary_10_1039_D2BM00562J crossref_primary_10_3390_biomedicines11030780 crossref_primary_10_3389_fnins_2021_596976 crossref_primary_10_3390_cancers13102391 crossref_primary_10_1007_s11307_017_1058_x crossref_primary_10_1002_jum_16315 crossref_primary_10_1111_nyas_14787 crossref_primary_10_1002_smll_201903460 crossref_primary_10_1038_s41598_021_83874_x crossref_primary_10_1259_bjr_20190214 crossref_primary_10_1177_1759091419884859 crossref_primary_10_1016_j_ultrasmedbio_2021_06_012 crossref_primary_10_3390_pharmaceutics14061283 crossref_primary_10_1021_acsami_7b19716 crossref_primary_10_3390_pharmaceutics15071896 crossref_primary_10_1038_srep37094 crossref_primary_10_1016_j_cis_2021_102407 crossref_primary_10_1248_bpb_b21_00453 crossref_primary_10_1007_s40846_018_0406_x crossref_primary_10_1080_10717544_2022_2157068 crossref_primary_10_1093_brain_awaa072 crossref_primary_10_1124_jpet_117_243014 crossref_primary_10_1109_TUFFC_2020_3019932 crossref_primary_10_1007_s11060_021_03820_9 crossref_primary_10_1007_s11060_022_03973_1 crossref_primary_10_1016_j_neurol_2022_03_015 crossref_primary_10_1002_adma_202000512 crossref_primary_10_1039_D0TB02832K crossref_primary_10_1016_j_nec_2020_08_002 crossref_primary_10_1007_s10585_017_9861_y crossref_primary_10_3390_pharmaceutics15010059 crossref_primary_10_1016_j_ultrasmedbio_2018_12_014 crossref_primary_10_1021_acs_jmedchem_1c01946 crossref_primary_10_3389_fonc_2018_00338 crossref_primary_10_1039_C7MH00342K crossref_primary_10_1007_s10396_022_01201_x crossref_primary_10_1038_s44222_023_00138_1 crossref_primary_10_1002_mds_27675 crossref_primary_10_1021_acsnano_4c11006 crossref_primary_10_3390_pharmaceutics13010015 crossref_primary_10_1016_j_jconrel_2024_10_023 crossref_primary_10_1038_nrd_2018_109 crossref_primary_10_1038_s41571_023_00756_z crossref_primary_10_1016_j_jconrel_2024_06_043 crossref_primary_10_1089_hum_2020_105 crossref_primary_10_1109_TBME_2019_2904702 crossref_primary_10_1016_j_jconrel_2024_06_036 crossref_primary_10_1002_adtp_202100147 crossref_primary_10_1007_s13311_020_00864_z crossref_primary_10_1016_j_wneu_2019_07_096 crossref_primary_10_1148_radiol_2019181625 crossref_primary_10_1007_s12551_020_00752_y crossref_primary_10_1097_WCO_0000000000001314 crossref_primary_10_3892_ijmm_2024_5378 crossref_primary_10_5694_mja16_01013 crossref_primary_10_1080_02656736_2024_2389288 crossref_primary_10_14801_jkiit_2022_20_12_141 crossref_primary_10_1186_s13195_022_00981_1 crossref_primary_10_1016_j_ultrasmedbio_2020_01_002 crossref_primary_10_3390_cancers14215341 crossref_primary_10_1002_smll_202203678 crossref_primary_10_1038_s41598_019_55629_2 crossref_primary_10_1016_j_jconrel_2020_06_024 crossref_primary_10_1016_j_jconrel_2018_12_009 crossref_primary_10_1016_j_apmt_2021_101028 crossref_primary_10_1093_neuonc_noab057 crossref_primary_10_1016_j_rx_2024_05_012 crossref_primary_10_1038_s41598_023_40522_w crossref_primary_10_1007_s40843_024_2993_4 crossref_primary_10_3390_neurosci3010001 crossref_primary_10_1007_s11060_019_03204_0 crossref_primary_10_1016_j_ebiom_2022_104277 crossref_primary_10_3390_pharmaceutics12010069 crossref_primary_10_1016_j_ultrasmedbio_2019_07_683 crossref_primary_10_1371_journal_pone_0234182 crossref_primary_10_18632_oncotarget_24896 crossref_primary_10_3390_pharmaceutics12111085 crossref_primary_10_1002_advs_201700474 crossref_primary_10_1016_j_mattod_2021_08_013 crossref_primary_10_1016_j_neurot_2024_e00352 crossref_primary_10_1016_j_ultrasmedbio_2019_09_010 crossref_primary_10_1073_pnas_2221097120 crossref_primary_10_3390_pharmaceutics14102231 crossref_primary_10_1016_j_ultrasmedbio_2019_02_024 crossref_primary_10_1038_s41467_022_28785_9 crossref_primary_10_1016_j_omtn_2016_11_002 crossref_primary_10_1002_mp_14947 crossref_primary_10_1016_j_addr_2018_10_001 crossref_primary_10_1126_science_adp7206 crossref_primary_10_1146_annurev_chembioeng_060817_084034 crossref_primary_10_1002_pbc_28983 crossref_primary_10_1007_s11060_023_04517_x crossref_primary_10_1038_s41467_024_45818_7 crossref_primary_10_1016_j_rxeng_2024_05_004 crossref_primary_10_3389_fphar_2019_01299 crossref_primary_10_3389_fphar_2019_00086 crossref_primary_10_3390_pharmaceutics16070849 crossref_primary_10_3390_cancers14164023 crossref_primary_10_1007_s11060_021_03887_4 crossref_primary_10_1016_j_ultrasmedbio_2020_01_027 crossref_primary_10_3389_fneur_2023_1274642 crossref_primary_10_1016_j_jconrel_2019_11_013 crossref_primary_10_1016_j_neubiorev_2020_06_007 crossref_primary_10_3171_2018_9_JNS182001 crossref_primary_10_1002_advs_202304453 crossref_primary_10_1016_j_conb_2018_03_009 crossref_primary_10_3390_ijms23084393 crossref_primary_10_1186_s40824_023_00377_8 crossref_primary_10_1186_s41231_022_00115_7 crossref_primary_10_1007_s13311_018_00702_3 crossref_primary_10_1016_j_jconrel_2019_05_014 crossref_primary_10_1038_s41571_021_00529_6 crossref_primary_10_3390_pharmaceutics15020455 crossref_primary_10_1051_medsci_2019223 crossref_primary_10_1017_jfm_2024_1124 crossref_primary_10_3390_cancers14194920 crossref_primary_10_1016_j_jconrel_2018_11_009 crossref_primary_10_1088_1741_2552_abdfb1 crossref_primary_10_1016_j_jconrel_2019_07_023 crossref_primary_10_1002_adma_201606596 crossref_primary_10_1016_j_ultrasmedbio_2020_02_017 crossref_primary_10_1002_advs_202401731 crossref_primary_10_1038_s41416_022_01864_w crossref_primary_10_1038_s41598_020_65617_6 crossref_primary_10_1158_1078_0432_CCR_19_2182 crossref_primary_10_1002_adhm_202402877 crossref_primary_10_1186_s13024_020_0358_9 crossref_primary_10_1021_acs_bioconjchem_4c00137 crossref_primary_10_3389_fphar_2020_00954 crossref_primary_10_3390_s23031369 crossref_primary_10_1016_j_jconrel_2021_01_023 crossref_primary_10_1021_acs_bioconjchem_3c00446 crossref_primary_10_1148_radiol_2021204441 crossref_primary_10_1073_pnas_2021915118 crossref_primary_10_1016_j_xinn_2023_100548 crossref_primary_10_1109_TBME_2021_3132014 crossref_primary_10_1016_j_jconrel_2022_03_035 crossref_primary_10_1109_TUFFC_2020_3035784 crossref_primary_10_1016_j_ijpharm_2020_119886 crossref_primary_10_1016_j_ultrasmedbio_2022_12_011 crossref_primary_10_1016_j_addr_2020_07_005 crossref_primary_10_1016_S1470_2045_18_30827_1 crossref_primary_10_1016_j_bulcan_2021_06_002 crossref_primary_10_3389_fneur_2022_880814 crossref_primary_10_1002_wnan_1913 crossref_primary_10_1016_j_ultrasmedbio_2017_06_029 crossref_primary_10_1109_TBME_2020_3047575 crossref_primary_10_3390_cancers14051124 crossref_primary_10_3171_2019_10_JNS191674 crossref_primary_10_1007_s11060_023_04492_3 crossref_primary_10_3389_fphy_2021_636985 crossref_primary_10_1364_BOE_9_004527 crossref_primary_10_3917_re1_103_0033 crossref_primary_10_3390_pharmaceutics15102479 crossref_primary_10_1016_S1470_2045_23_00112_2 crossref_primary_10_1016_j_jconrel_2022_03_043 crossref_primary_10_3390_ijms23126671 crossref_primary_10_4155_tde_2016_0048 crossref_primary_10_3390_app6110365 crossref_primary_10_1002_adfm_202102265 crossref_primary_10_3390_brainsci11030386 crossref_primary_10_1016_j_jconrel_2018_11_028 crossref_primary_10_1016_j_biopha_2022_113394 crossref_primary_10_1007_s13311_022_01251_6 crossref_primary_10_1016_j_addr_2021_113832 crossref_primary_10_1016_j_cclet_2024_109996 crossref_primary_10_1016_j_nec_2020_06_010 crossref_primary_10_1038_s41598_017_00705_8 crossref_primary_10_1080_17425247_2019_1567490 crossref_primary_10_3389_fphy_2020_00137 crossref_primary_10_1093_neuonc_noae215 crossref_primary_10_1016_j_ultrasmedbio_2021_03_007 crossref_primary_10_1159_000502483 crossref_primary_10_1073_pnas_1713328114 crossref_primary_10_3390_pharmaceutics16101289 crossref_primary_10_1002_adma_201805697 crossref_primary_10_1016_j_xphs_2020_06_008 crossref_primary_10_1109_TBME_2021_3077802 crossref_primary_10_1371_journal_pone_0310425 crossref_primary_10_1016_j_addr_2021_113847 crossref_primary_10_3389_fphy_2021_654374 crossref_primary_10_1109_TMI_2021_3140176 crossref_primary_10_1016_j_ejpb_2024_114234 crossref_primary_10_1038_s41598_020_75253_9 crossref_primary_10_3389_fonc_2021_694320 crossref_primary_10_1126_sciadv_abd0772 crossref_primary_10_1016_j_nec_2020_06_009 crossref_primary_10_1016_j_jconrel_2019_12_006 crossref_primary_10_1038_s41598_023_33671_5 crossref_primary_10_3389_fonc_2022_1072780 crossref_primary_10_1016_j_yao_2023_01_017 |
ContentType | Journal Article |
Copyright | Copyright © 2016, American Association for the Advancement of Science. |
Copyright_xml | – notice: Copyright © 2016, American Association for the Advancement of Science. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1126/scitranslmed.aaf6086 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1946-6242 |
ExternalDocumentID | 27306666 |
Genre | Clinical Trial, Phase II Clinical Trial, Phase I Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 4.4 53G 7~K ABJNI ACGFS AENEX AJGZS AJWWR ALMA_UNASSIGNED_HOLDINGS BKF C45 CGR CUY CVF DU5 EBS ECM EIF EJD EMOBN F5P HZ~ NPM O9- OFXIZ OVD OVIDX P2P RHI TEORI |
ID | FETCH-LOGICAL-c406t-f70157d6ec96ab8d7f67531e2a689d274d37afb10bc282fbf6b34d1f6ee8cc8f2 |
IngestDate | Wed Feb 19 02:43:30 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 343 |
Language | English |
License | Copyright © 2016, American Association for the Advancement of Science. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c406t-f70157d6ec96ab8d7f67531e2a689d274d37afb10bc282fbf6b34d1f6ee8cc8f2 |
PMID | 27306666 |
ParticipantIDs | pubmed_primary_27306666 |
PublicationCentury | 2000 |
PublicationDate | 2016-06-15 |
PublicationDateYYYYMMDD | 2016-06-15 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Science translational medicine |
PublicationTitleAlternate | Sci Transl Med |
PublicationYear | 2016 |
SSID | ssj0068356 |
Score | 2.6401606 |
Snippet | The blood-brain barrier (BBB) limits the delivery of systemically administered drugs to the brain. Methods to circumvent the BBB have been developed, but none... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 343re2 |
SubjectTerms | Blood-Brain Barrier - drug effects Blood-Brain Barrier - radiation effects Blood-Brain Barrier - surgery Brain - drug effects Brain - radiation effects Brain - surgery Carboplatin - therapeutic use Female Glioblastoma - drug therapy Glioblastoma - surgery Humans Magnetic Resonance Imaging Male Microbubbles Ultrasonic Waves |
Title | Clinical trial of blood-brain barrier disruption by pulsed ultrasound |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27306666 |
Volume | 8 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFLYKSBOXicEGbGzygRtK1SSukxynCoSQ2GECxA35x_MUCdIqTQ9w5R_fc2yvVikS7BI1sRI1-b7Y33Pe50fIcYmqm4EaJ2MuRcKyAhKhIE9AFmBS4Fr3kzmXv_j5Nbu4Hd8OBs9R1tKik0P1tNZX8j-o4jHE1bpk34Hsv4viAfyN-OIWEcbtmzCeBFujq72Bus_loUtb9-FEirYvR6frebtwPQNqzdkCB0N9srjvWjG3NZVieRre9M6OYPdhnnD1-_vEfrNputoXwnYWmTZqDilkcU6-LepV_2mm3dpzfkPtzGk3daNCLo6fjEi5TZpydswhuA60YjyxnpO4hy0jIuUsj_pL3GshW9-Vh-KT7pbxVodCGD5yK2dH6M4eenhRh9lY7A2tKwtsh6YNsoGhhq2daid83GDOUaBy77j0XqsXf8euJ-0vsRKb9Brlaod89MEF_emY8okMoNklHy49fHvkNBCG9oShU0MjwlBPGLokDJWP1BGGLgnzmVyfnV5NzhNfRyNRKNe6xBSo-QrNQVVcyFIXBqPEPIVM8LLSWcF0Xggj05FUGIAbabjMmU4NByiVKk32hWw20wYOCMV4Nx8Zaf3JwAomKlGWYFCGGkA26OqQ7LsHcDdzi6XchUfz9dWWb2R7SaUjsmXw7YTvKPU6-aMH4y_h7lsU |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+trial+of+blood-brain+barrier+disruption+by+pulsed+ultrasound&rft.jtitle=Science+translational+medicine&rft.au=Carpentier%2C+Alexandre&rft.au=Canney%2C+Michael&rft.au=Vignot%2C+Alexandre&rft.au=Reina%2C+Vincent&rft.date=2016-06-15&rft.eissn=1946-6242&rft.volume=8&rft.issue=343&rft.spage=343re2&rft_id=info:doi/10.1126%2Fscitranslmed.aaf6086&rft_id=info%3Apmid%2F27306666&rft_id=info%3Apmid%2F27306666&rft.externalDocID=27306666 |